Characterization of Bacillus probiotics available for human use

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Commercial probiotic products often contain Bacillus spores.
• Understanding the probiotic potential of these bacteria is crucial for consumer safety and efficacy.

Purpose of the Study:

• To characterize Bacillus species (B. cereus, B. clausii, B. pumilus) from probiotic products for key probiotic attributes.
• To assess their safety for human use.

Main Methods:

• In vivo colonization studies in mice.
• In vitro assessment of spore resistance to gastrointestinal conditions.
• Immunogenicity testing via oral administration in mice.
• Cytokine induction analysis in macrophage cell lines and in vivo.
• Antimicrobial activity assays against other Bacillus species.
• Enterotoxin detection for safety assessment.

Main Results:

• Three B. cereus strains demonstrated gastrointestinal colonization in mice for up to 18 days.
• B. pumilus spores induced significant anti-spore immunoglobulin G titers and proinflammatory cytokines (IL-6, TNF-α) and Th1 cytokine (IFN-γ).
• B. pumilus and one B. cereus strain exhibited antimicrobial activity against other Bacillus species.
• All three B. cereus strains produced Hbl and Nhe enterotoxins, indicating potential safety concerns.

Conclusions:

• Bacillus spores possess attributes like colonization, immunostimulation, and antimicrobial activity, supporting their probiotic potential.
• The presence of enterotoxins in B. cereus strains raises significant safety concerns for human consumption.
• Further research is needed to identify safe and effective Bacillus strains for probiotic applications.